TKT and neoplasm: Compared with mice injected with tumor cells pre-mixed with control VLPs, tk-VLP mixture–injected mice had significantly less intracranial tumor fluorescence from day 42 on as determined through in vivo FMT imaging (Fig. 3a and Supplementary Fig. 2) and had significantly better survival (Fig. 3b).